DE69024672T2 - Sprays zur Behandlung von Infektionen des Tractus Respiratorius - Google Patents

Sprays zur Behandlung von Infektionen des Tractus Respiratorius

Info

Publication number
DE69024672T2
DE69024672T2 DE69024672T DE69024672T DE69024672T2 DE 69024672 T2 DE69024672 T2 DE 69024672T2 DE 69024672 T DE69024672 T DE 69024672T DE 69024672 T DE69024672 T DE 69024672T DE 69024672 T2 DE69024672 T2 DE 69024672T2
Authority
DE
Germany
Prior art keywords
sprays
treatment
respiratory tract
tract infections
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69024672T
Other languages
English (en)
Other versions
DE69024672D1 (de
Inventor
Derek Bryce-Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kappa Pharmaceuticals Ltd
Original Assignee
Kappa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Pharmaceuticals Ltd filed Critical Kappa Pharmaceuticals Ltd
Publication of DE69024672D1 publication Critical patent/DE69024672D1/de
Application granted granted Critical
Publication of DE69024672T2 publication Critical patent/DE69024672T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
DE69024672T 1989-02-02 1990-02-02 Sprays zur Behandlung von Infektionen des Tractus Respiratorius Expired - Lifetime DE69024672T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898902300A GB8902300D0 (en) 1989-02-02 1989-02-02 Antirhinoviral preparations

Publications (2)

Publication Number Publication Date
DE69024672D1 DE69024672D1 (de) 1996-02-22
DE69024672T2 true DE69024672T2 (de) 1996-08-14

Family

ID=10651009

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69024672T Expired - Lifetime DE69024672T2 (de) 1989-02-02 1990-02-02 Sprays zur Behandlung von Infektionen des Tractus Respiratorius

Country Status (11)

Country Link
US (1) US5622724A (de)
EP (1) EP0381522B1 (de)
JP (1) JPH03197430A (de)
AT (1) ATE132747T1 (de)
AU (1) AU652337B2 (de)
CA (1) CA2009221C (de)
DE (1) DE69024672T2 (de)
ES (1) ES2080787T3 (de)
GB (1) GB8902300D0 (de)
IE (1) IE71664B1 (de)
NZ (1) NZ232356A (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916625D0 (en) * 1989-07-20 1989-09-06 Bryce Smith Derek Respiratory tract spray preparations
DE4205828A1 (de) * 1992-02-26 1993-09-02 Henkel Kgaa Viruswirksame desinfektionsmittel
US5897872A (en) * 1997-11-12 1999-04-27 Picciano; Dante J. Iodine-containing nasal moisturizing saline solution
US6171611B1 (en) 1997-11-12 2001-01-09 Dante J. Picciano Iodine-containing nasal moisturizing saline and mouthwash solutions
ES2136033B1 (es) * 1997-12-10 2000-05-16 Tudela Bernardo Hernandez Producto contra el resfriado con compuestos de zinc
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
US6080783A (en) 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
US20040234457A1 (en) * 1999-10-19 2004-11-25 The Procter & Gamble Company Methods of preventing and treating SARS using low pH respiratory tract compositions
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US9072753B1 (en) * 2000-04-03 2015-07-07 Amy C. Brown Gargle method to reduce the duration of common cold symptoms
US20030215491A1 (en) * 2001-04-30 2003-11-20 Hensley Charles B. Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane
US6929800B2 (en) * 2001-08-06 2005-08-16 Abdul Rasoul Salman Nasal passage cleaning composition
NL1020832C2 (nl) * 2002-06-12 2003-12-15 P K Benelux B V Farmaceutische samenstelling voor nasale toediening met een zinkverbinding, en toepassing.
AU2003266159A1 (en) * 2002-09-16 2004-04-30 Zicam, Llc. System and method for delivering a composition to the nasal membrane
WO2004064742A2 (en) * 2003-01-17 2004-08-05 Uab Research Foundation Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms
US20040180006A1 (en) * 2003-03-12 2004-09-16 Sceusa Nicholas A. Methods and compositions for blocking the calcium cascade
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
CA2588782A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
EP1830638A2 (de) * 2004-12-09 2007-09-12 The Dial Corporation Zusammensetzungen mit starker antiviraler und antibakterieller wirksamkeit
CA2588802A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
RU2380099C2 (ru) * 2004-12-09 2010-01-27 Дзе Дайл Корпорэйшн Композиции, имеющие высокую противовирусную и антибактериальную эффективность
JP5038331B2 (ja) 2006-02-03 2012-10-03 ジェイアール ケム エルエルシー 銅と亜鉛の組成物を用いた老化防止治療
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US20070275929A1 (en) * 2006-05-24 2007-11-29 The Dial Corporation Composition and method for controlling the transmission of noroviruses
EP2040544A2 (de) * 2006-05-26 2009-04-01 The Dial Corporation Verfahren zur hemmung der übertragung von viren
WO2007142919A2 (en) * 2006-05-30 2007-12-13 The Dial Corporation Compositions having a high antiviral effeicacy
US20070281999A1 (en) * 2006-05-31 2007-12-06 The Dial Corporation Alcohol-containing antimicrobial compositions having improved efficacy
EP2034826A2 (de) 2006-06-02 2009-03-18 The Dial Corporation Verfahren zur hemmung der übertragung des influenza-virus
RU2008152442A (ru) * 2006-06-05 2010-07-20 Дзей Дайл Корпорейшн (Us) Способы и изделия, имеющие высокую противовирусную и противобактериальную эффективность
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8513420B2 (en) * 2007-03-19 2013-08-20 Monika Mazik Amino-naphthyridine derivatives
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US20150174137A1 (en) * 2010-06-02 2015-06-25 Alcon Research, Ltd. Compositions for treating microbial infections
BR112013008244A8 (pt) * 2010-10-06 2018-02-14 Bausch & Lomb composições de bepotastina
US20120323178A1 (en) 2011-01-04 2012-12-20 Mitsubishi Tanabe Pharma Corporation Bepotastine compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9944577B2 (en) 2012-10-25 2018-04-17 Baker Hughes, A Ge Company, Llc Hydroquinone compounds for inhibiting monomer polymerization
US9611336B2 (en) 2012-10-25 2017-04-04 Baker Hughes Incorporated Quinone compounds for inhibiting monomer polymerization
US20180147140A1 (en) * 2016-11-30 2018-05-31 Darryl Thomas Finn Treatment and Prevention of ENT Infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852432A (en) * 1971-01-18 1974-12-03 Department Of Health Education Diagnostic device and method of treatment
SE393532B (sv) * 1974-05-02 1977-05-16 Draco Ab Sett att framstella en farmaceutisk zinkberedning for astadkommande av en smaklig, fordragbar, peroral zinklosning innehallande ett zinkkomplex
US4255419A (en) * 1979-09-27 1981-03-10 Allergan Pharmaceuticals, Inc. Zinc deficiency in multiple sclerosis
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
US5002970A (en) * 1981-07-31 1991-03-26 Eby Iii George A Flavor masked ionizable zinc compositions for oral absorption
US4956385A (en) * 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
DE3443985A1 (de) * 1984-12-01 1986-06-05 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Arzneimittelzubereitungen gegen mykotische und bakterielle infektionen mit einem gehalt an wirkstoffen, welche zink in ionisierter form freisetzen
US4814164A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant composition
US4814163A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant
US4946688A (en) * 1988-07-05 1990-08-07 Fahim Mostafa S Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate
GB8916625D0 (en) * 1989-07-20 1989-09-06 Bryce Smith Derek Respiratory tract spray preparations

Also Published As

Publication number Publication date
EP0381522B1 (de) 1996-01-10
AU4907290A (en) 1990-08-09
GB8902300D0 (en) 1989-03-22
JPH03197430A (ja) 1991-08-28
CA2009221C (en) 2000-10-17
CA2009221A1 (en) 1990-08-02
ATE132747T1 (de) 1996-01-15
US5622724A (en) 1997-04-22
NZ232356A (en) 1991-10-25
DE69024672D1 (de) 1996-02-22
IE71664B1 (en) 1997-02-26
EP0381522A1 (de) 1990-08-08
AU652337B2 (en) 1994-08-25
ES2080787T3 (es) 1996-02-16
IE900390L (en) 1990-08-02

Similar Documents

Publication Publication Date Title
DE69024672D1 (de) Sprays zur Behandlung von Infektionen des Tractus Respiratorius
DE69033112T2 (de) Zink enthaltende Sprays
DE69600307D1 (de) Beatmungsgerät zur Behandlung von Ateminsuffizienzen
DE59000518D1 (de) Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen.
EP0403303A3 (de) Haarbehandlungszusammensetzung
DE10299005I1 (de) Verwendung von 1-Beta-D-ribofuranosyl-1,2,4-triazol-3-carboxamid (Ribavirin) zur Herstellung eines Medikaments fuer die Behandlung von Arboviren
DE69223455T2 (de) WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
DK120892D0 (da) Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
FR2694500B1 (fr) Nébuliseur polyvalent pour le traitement des voies respiratoires.
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GRAMM, LINS & PARTNER GBR, 30173 HANNOVER